Xeomin

Merz North America, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 10, 2026
Approval ID: 3f35d6e0-3450-4abc-a0da-cc7b277e7c6e
Products: 3 registered
Version: 27

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XEOMIN safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010

Quick Stats

Total Products3

Labelers2

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.